It was a busy week for clinical trial news. Here’s a look. COVID-19-Related PureTech Health presented data from the Phase I multiple ascending dose and food effect study of LYT-100. LYT-100 is a deuterated form of pirfenidone, an approved anti-inflammatory and anti-fibrotic drug. It is being developed for inflammatory and fibrotic disease, including lung disease and Long […]

Tampa-based Axogen, a life science company that is developing products for nerve repair, is ramping up hiring for scientists and engineers after navigating through the negative disruptions from the Covid-19 pandemic. Axogen (NASDAQ: AXGN), which works with hospitals in Tampa and St. Pete, has its second HQ in the Tampa Heights building where it currently […]

The Annual Biomarkers for Alzheimer’s Disease Summit is running from August 25-26. The industry’s only digital forum focused on sharing innovations in new novel biomarkers and clinically validated biomarkers for the earlier detection and diagnosis of Alzheimer’s disease, an area of intense unmet medical need. Here’s a look at some of the top stories from day one. […]